India, April 3 -- image credit- shutterstock

Lupin Healthcare (UK) Limited, the wholly owned subsidiary of Mumbai-based global pharma major Lupin Limited has announced the acquisition of Renascience Pharma Limited, a United Kingdom (UK)-based pharmaceutical company and sole supplier of 4 specialty products targeting unmet medical needs in the UK.

With this acquisition, Lupin Healthcare (UK) Limited gains full ownership of Renascience which, going forward, will trade as its subsidiary. The portfolio includes branded injectable cephalosporines for infectious diseases, a topical treatment for ear pain and a branded quinazoline-like diuretic for cardio- vascular and renal indications.

Commenting on the acquisition,Fabrice Egros, President ...